BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17279354)

  • 1. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport.
    D'Alessandris C; Lauro R; Presta I; Sesti G
    Diabetologia; 2007 Apr; 50(4):840-9. PubMed ID: 17279354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism.
    Miele C; Riboulet A; Maitan MA; Oriente F; Romano C; Formisano P; Giudicelli J; Beguinot F; Van Obberghen E
    J Biol Chem; 2003 Nov; 278(48):47376-87. PubMed ID: 12970360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
    Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
    Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.
    Pedrini MT; Kranebitter M; Niederwanger A; Kaser S; Engl J; Debbage P; Huber LA; Patsch JR
    Diabetologia; 2005 Apr; 48(4):756-66. PubMed ID: 15747109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.
    Hribal ML; Federici M; Porzio O; Lauro D; Borboni P; Accili D; Lauro R; Sesti G
    J Clin Endocrinol Metab; 2000 May; 85(5):2004-13. PubMed ID: 10843189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells.
    Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A
    Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells.
    Hajduch E; Balendran A; Batty IH; Litherland GJ; Blair AS; Downes CP; Hundal HS
    Diabetologia; 2001 Feb; 44(2):173-83. PubMed ID: 11270673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
    Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin.
    Palanivel R; Maida A; Liu Y; Sweeney G
    Diabetologia; 2006 Jan; 49(1):183-90. PubMed ID: 16341686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
    Henriksen EJ; Teachey MK
    Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle.
    Egawa T; Tsuda S; Ma X; Hamada T; Hayashi T
    J Appl Physiol (1985); 2011 Dec; 111(6):1629-36. PubMed ID: 21940847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HM-Chromanone, a Major Homoisoflavonoid in
    Park JE; Han JS
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    J Biol Chem; 2005 Mar; 280(11):9855-64. PubMed ID: 15764607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
    Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
    Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation.
    Yaluri N; Modi S; Kokkola T
    Biochem Biophys Res Commun; 2016 Nov; 480(2):194-200. PubMed ID: 27743890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.